.Pharmacolibrary.Drugs.ATC.N.N05AC03 .Pharmacolibrary.Drugs.ATC.N.N05AC03| name: | Mesoridazine | |
| ATC code: | N05AC03 | route: | oral |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 14.0 | L |
| clearance: | 20 | L/h |
| other parameters in model implementation | ||
Mesoridazine is a piperidine phenothiazine antipsychotic drug formerly used in the treatment of schizophrenia and other psychotic disorders. It is a metabolite of thioridazine. Mesoridazine was withdrawn from the market in many countries, including the United States, due to risk of QT prolongation and serious arrhythmias.
Estimated pharmacokinetic parameters based on available tertiary literature for orally administered mesoridazine in adult subjects, as no peer-reviewed primary pharmacokinetic publication was identified.